Physician profile
Sandra M Saint-Eloi
NPI 1730126418
$2,273.87
in general payments reported to CMS, 2019-2025
32 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Gerontology (Registered Nurse) provider received nationally (typical 2025 total: $85.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $587 · 2022: $353 · 2023: $535 · 2024: $568 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,318 · Travel and Lodging: $15.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,318.29 |
| Travel and Lodging | $15.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $317.97 | 2022-2025 | |
| Astellas Pharma US INC | $305.28 | 2021-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $281.05 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $173.07 | 2021-2025 | Rexulti, Jynarque |
| Sunovion Pharmaceuticals INC. | $135.87 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $132.12 | 2021-2023 | Gvoke Hypopen |
| Angiodynamics, INC. | $121.27 | 2021 | |
| Exact Sciences Corporation | $93.34 | 2023-2025 | Cologuard Collection Kit |
| Neurocrine Biosciences, INC. | $49.13 | 2023-2024 | Ingrezza |
| Avanir Pharmaceuticals, INC. | $46.19 | 2021 | |
| Sumitomo Pharma America, INC. | $44.11 | 2023 | Gemtesa |
| Pfizer INC. | $40.99 | 2023-2025 | |
| Cmp Pharma, INC. | $40.37 | 2022 | |
| Aquestive Therapeutics, INC. | $40.30 | 2021 | |
| Amarin Pharma, INC. | $39.58 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $38.05 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $36.09 | 2023 | Kristalose |
| Astrazeneca Pharmaceuticals Lp | $33.38 | 2021 | |
| Acella Pharmaceuticals, LLC | $32.26 | 2024-2025 | NP Thyroid 60 |
| Novo Nordisk INC | $27.47 | 2025 | Wegovy |
| Harmony Biosciences LLC | $27.17 | 2021 | |
| Lilly USA, LLC | $26.19 | 2023 | Trulicity |
| Ultragenyx Pharmaceutical INC. | $24.66 | 2023 | Crysvita |
| Eisai INC. | $22.71 | 2021 | |
| Bsn Medical INC | $20.35 | 2022 | |
| Horizon Therapeutics Plc | $19.87 | 2023 | Krystexxa |
| Amgen INC. | $19.37 | 2021 | |
| Smith+Nephew, INC. | $19.32 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $18.80 | 2023 | Bard Urinary Drainage Bag |
| Novartis Pharmaceuticals Corporation | $17.50 | 2024 | |
| Biogen, INC. | $15.83 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Saint-Eloi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.